Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$22.90 - $36.45
Next Earnings Date
May 01 2025
Next Earnings Date
May 01 2025
Latest price
Market Cap | $4.48B |
EV | $3.80B |
Shares Outstanding | 164.84M |
Beta | 0.35 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | $39.71 |
P/E 2025E | 15.20x |
P/Revenue 2025E | 3.22x |
Revenue | 9.90% |
EPS | 54.70% |
Operating Cash Flow | 62.80% |
Free Cash Flow | 76.60% |
Revenue | -3.00% |
EPS | -19.30% |
Operating Cash Flow | -7.10% |
Free Cash Flow | -5.10% |
Gross Margin 2025E | 86.40% |
Net Profit Margin 2025E | 13.52% |
ROE 2025E | 19.43% |
ROCE 2024 | 27.90% |
DPS 2025E | $0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Alkermes plc
ALKS
Sector
Healthcare
Industry
Biotechnology
CEO
Pops, Richard
Employees
1,800
Website
www.alkermes.comIPO Date
1991-07-16
Headquarters
Connaught House, 1 Burlington Road, Dublin 4, Dublin, Co. Dublin, D04 C5Y6, Ireland
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved